Patient Activity and Survival Following Implantable Cardioverter-Defibrillator Implantation: The ALTITUDE Activity Study

被引:50
|
作者
Kramer, Daniel B. [1 ,2 ,3 ]
Mitchell, Susan L. [1 ,2 ,3 ]
Monteiro, Joao [4 ]
Jones, Paul W. [5 ]
Normand, Sharon-Lise [2 ,6 ]
Hayes, David L. [7 ]
Reynolds, Matthew R. [8 ,9 ]
机构
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Hebrew SeniorLife Inst Aging Res, Boston, MA USA
[4] North Amer Sci Associates Inc, Minneapolis, MN USA
[5] Boston Sci, St Paul, MN USA
[6] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[7] Mayo Clin, Rochester, MN USA
[8] Lahey Clin Fdn, Burlington, MA USA
[9] Harvard Clin Res Inst, Boston, MA USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2015年 / 4卷 / 05期
关键词
death; implantable cardioverter-defibrillators; sudden; CARDIAC RESYNCHRONIZATION THERAPY; HEART-FAILURE; PHYSICAL-ACTIVITY; SHOCK THERAPY; MORTALITY; RISK; REPLACEMENT; DEVICES; VALIDATION; RECIPIENTS;
D O I
10.1161/JAHA.115.001775
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Physical activity data are collected automatically by implantable cardioverter-defibrillators (ICDs). Though these data potentially provide a quantifiable and easily accessible measure of functional status, its relationship with survival has not been well studied. Methods and Results-Patients enrolled in the Boston Scientific LATITUDE remote monitoring system from 2008 to 2012 with ICDs were eligible. Remote monitoring data were used to calculate mean daily activity at baseline (30 to 60 days after implantation), and longitudinally. Cox regression was used to examine the association between survival and increments of 30 minutes/day in both (1) mean baseline activity and (2) time-varying activity, with both adjusted for demographic and device characteristics. A total of 98 437 patients were followed for a median of 2.2 years (mean age of 67.7 +/- 13.1 years; 71.7% male). Mean baseline daily activity was 107.5 +/- 66.2 minutes/day. The proportion of patients surviving after 4 years was significantly higher among those in the most versus least active quintile of mean baseline activity (90.5% vs. 50.0%; log-rank P value, <0.001). Lower mean baseline activity (i.e., incremental difference of 30-minutes/day) was independently associated with a higher risk of death (adjusted hazard ratio [AHR], 1.44; 95% confidence interval [CI], 1.427 to 1.462). Time-varying activity was similarly associated with a higher risk of death (AHR, 1.48; 95% CI, 1.451 to 1.508), indicating that a patient having 30 minutes per day less activity in a given month has a 48% increased hazard for death when compared to a similar patient in the same month. Conclusions-Patient activity measured by ICDs strongly correlates with survival following ICD implantation.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Early Increased Physical Activity, Cardiac Rehabilitation, and Survival After Implantable Cardioverter-Defibrillator Implantation
    Atwater, Brett D.
    Li, Zhen
    Pritchard, Jessica
    Greiner, Melissa A.
    Nabutovsky, Yelena
    Hammill, Bradley G.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2021, 14 (08): : E007580
  • [2] Survival Following Implantable Cardioverter-Defibrillator Implantation in Patients With Amyloid Cardiomyopathy
    Higgins, Angela Y.
    Annapureddy, Amarnath R.
    Wang, Yongfei
    Minges, Karl E.
    Lampert, Rachel
    Rosenfeld, Lynda E.
    Jacoby, Daniel L.
    Curtis, Jeptha P.
    Miller, Edward J.
    Freeman, James V.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (18):
  • [3] Survival After Implantable Cardioverter-Defibrillator Implantation in the Elderly
    Yung, Derek
    Birnie, David
    Dorian, Paul
    Healey, Jeffrey S.
    Simpson, Christopher S.
    Crystal, Eugene
    Krahn, Andrew D.
    Khaykin, Yaariv
    Cameron, Douglas
    Chen, Zhongliang
    Lee, Douglas S.
    CIRCULATION, 2013, 127 (24) : 2383 - 2392
  • [4] Prophylactic implantable cardioverter-defibrillator in the very elderly
    Zakine, Cyril
    Garcia, Rodrigue
    Narayanan, Kumar
    Gandjbakhch, Estelle
    Algalarrondo, Vincent
    Lellouche, Nicolas
    Perier, Marie-Cecile
    Fauchier, Laurent
    Gras, Daniel
    Bordachar, Pierre
    Piot, Olivier
    Babuty, Dominique
    Sadoul, Nicolas
    Defaye, Pascal
    Deharo, Jean-Claude
    Klug, Didier
    Leclercq, Christophe
    Extramiana, Fabrice
    Boveda, Serge
    Marijon, Eloi
    EUROPACE, 2019, 21 (07): : 1063 - 1069
  • [5] The subcutaneous implantable cardioverter-defibrillator
    Grace, Andrew
    CURRENT OPINION IN CARDIOLOGY, 2014, 29 (01) : 10 - 19
  • [6] Survival After Implantable Cardioverter-Defibrillator Shocks
    Aktas, Mehmet K.
    Younis, Arwa
    Zareba, Wojciech
    Kutyifa, Valentina
    Klein, Helmut
    Daubert, James P.
    Estes, Mark
    McNitt, Scott
    Polonsky, Bronislava
    Goldenberg, Ilan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (20) : 2453 - 2462
  • [7] Safety of Outpatient Implantation of the Implantable Cardioverter-defibrillator
    Datino, Tomas
    Miracle Blanco, Angel
    Nunez Garcia, Alberto
    Gonzalez-Torrecilla, Esteban
    Atienza Fernandez, Felipe
    Arenal Maiz, Angel
    Hernandez-Hernandez, Jesus
    Avila Alonso, Pablo
    Eidelman, Gabriel
    Fernandez-Aviles, Francisco
    REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (07): : 579 - 584
  • [8] Implantable Cardioverter-Defibrillator Registry Risk Score Models for Acute Procedural Complications or Death After Implantable Cardioverter-Defibrillator Implantation
    Haines, David E.
    Wang, Yongfei
    Curtis, Jeptha
    CIRCULATION, 2011, 123 (19) : 2069 - 2076
  • [9] Incidence of Appropriate Cardioverter-Defibrillator Shocks and Mortality in Patients With Heart Failure Treated With Combined Cardiac Resynchronization Plus Implantable Cardioverter-Defibrillator Therapy Versus Implantable Cardioverter-Defibrillator Therapy
    Desai, Harit
    Aronow, Wilbert S.
    Ahn, Chul
    Tsai, Fausan S.
    Lai, Hoang M.
    Gandhi, Kaushang
    Amin, Harshad
    Frishman, William H.
    Kalapatapu, Kumar
    Cohen, Martin
    Sorbera, Carmine
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 15 (01) : 37 - 40
  • [10] Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population
    Levy, Wayne C.
    Lee, Kerry L.
    Hellkamp, Anne S.
    Poole, Jeanne E.
    Mozaffarian, Dariush
    Linker, David T.
    Maggioni, Aldo P.
    Anand, Inder
    Poole-Wilson, Philip A.
    Fishbein, Daniel P.
    Johnson, George
    Anderson, Jill
    Mark, Daniel B.
    Bardy, Gust H.
    CIRCULATION, 2009, 120 (10) : 835 - 842